STANDARDIZED VISUAL ACUITY RESULTS ASSOCIATED WITH PRIMARY VERSUS SECONDARY BEVACIZUMAB (AVASTIN) TREATMENT FOR CHOROIDAL NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATION-Reference-Cited by-同舟云学术

STANDARDIZED VISUAL ACUITY RESULTS ASSOCIATED WITH PRIMARY VERSUS SECONDARY BEVACIZUMAB (AVASTIN) TREATMENT FOR CHOROIDAL NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATION

Published:2007-07 Issue:6 Volume:27 Page:701-706
ISSN:0275-004X
Container-title:Retina
language:en
Short-container-title:

Author:

FALKENSTEIN IRYNA A.,CHENG LINGYUN,MORRISON VICTORIA L.,KOZAK IGOR,TAMMEWAR AJAY M.,FREEMAN WILLIAM R.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Ophthalmology,General Medicine

Reference30 articles.

1. Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration.;Ferrara;Retina,2006

2. Avastin and new treatments for AMD: where are we?;Freeman;Retina,2006

3. Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration.;Rosenfeld;Ophthalmic Surg Lasers Imaging,2005

4. Treatment of choroidal neovascularization in pathologic myopia with intravitreal bevacizumab.;Laud;Retina,2006

5. Intravitreal bevacizumab (Avastin) as treatment for subfoveal choroidal neovascularization secondary to pathologic myopia.;Yamamoto;Br J Ophthalmol,2007

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration;Cochrane Database of Systematic Reviews;2019-03-04

2. Bevacizumab dosing every 2 weeks for neovascular age-related macular degeneration refractory to monthly dosing;Japanese Journal of Ophthalmology;2018-09-29

3. Assessment of bevacizumab quality and stability in repackaged syringes for clinical use;European Journal of Hospital Pharmacy;2016-03-21

4. SLO-Microperimetry in Wet Age-Related Macular Degeneration During Anti-VEGF Therapy;Ophthalmic Surgery, Lasers and Imaging Retina;2015-09

5. The Effects of the Frequency of the Initial Treatment with Intravitreal Bevacizumab on Macular Volume and Visual Acuity;Journal of Ocular Pharmacology and Therapeutics;2015-06